Earnings calendar/SUPN
Supernus Pharmaceuticals, Inc. (SUPN)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 3, 2026
Consensus estimate row
EPS target
$0.61
Street estimate
Revenue target
$218.3M
Street estimate
Trailing EPS (avg 4Q)
$0.76
Beat rate last 4: 100%
Latest EPS YoY
-40.7%
vs 2025-08-05
Latest revenue YoY
+32.4%
How results look so far
Trailing revenue (avg 4Q)
$207.6M
Printed quarters
EPS beat rate (4Q)
100%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 3, 2026
EPS beat
EPS actual / est
$0.54 / $0.42
+27.8%
Revenue actual / est
$219.1M / $205.3M
+6.7%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/3/2026upcoming | $0.61 | Pending | — | $218.3M | Pending | — |
| 8/3/2026 | $0.42 | $0.54 | +27.8% | $205.3M | $219.1M | +6.7% |
| 5/5/2026 | $0.28 | $0.59 | +110.7% | $192.9M | $207.7M | +7.7% |
| 2/24/2026 | $0.28 | $0.92 | +228.6% | $195.2M | $211.6M | +8.4% |
| 11/4/2025 | $0.82 | $1.01 | +23.2% | $194.7M | $192.1M | -1.3% |
| 8/5/2025 | $0.47 | $0.91 | +93.6% | $168.2M | $165.5M | -1.6% |
| 5/6/2025 | $0.38 | $0.42 | +10.5% | $147.9M | $149.8M | +1.3% |
| 2/25/2025 | $0.46 | $0.75 | +63.0% | $155.3M | $174.2M | +12.2% |
| 11/4/2024 | $0.39 | $1.06 | +171.8% | $154.5M | $175.7M | +13.7% |
| 8/6/2024 | $0.37 | $0.36 | -2.7% | $148.8M | $168.3M | +13.1% |
| 5/8/2024 | $0.38 | $0.26 | -31.6% | $145.8M | $143.6M | -1.5% |
| 2/27/2024 | $0.41 | $0.02 | -95.1% | $155.0M | $164.3M | +6.0% |
| 11/8/2023 | $0.13 | $-0.29 | -323.1% | $155.3M | $153.9M | -0.9% |
| 8/8/2023 | $0.23 | $-0.02 | -108.7% | $143.7M | $135.6M | -5.6% |
| 5/9/2023 | $0.17 | $0.29 | +70.6% | $139.0M | $153.8M | +10.6% |
| 2/28/2023 | $0.68 | $0.43 | -36.8% | $180.3M | $167.3M | -7.2% |
| 11/8/2022 | $0.36 | $0.03 | -91.7% | $172.5M | $177.4M | +2.8% |
| 8/4/2022 | $0.29 | $0.14 | -51.7% | $164.1M | $170.1M | +3.6% |
| 5/9/2022 | $0.26 | $0.43 | +65.4% | $153.9M | $152.5M | -0.9% |
| 4/13/2022 | $0.24 | $0.04 | -83.3% | $153.9M | $152.5M | -0.9% |
| 2/28/2022 | $0.24 | $0.04 | -81.3% | $148.4M | $159.1M | +7.2% |
| 11/3/2021 | $0.23 | $0.40 | +73.9% | $118.1M | $148.5M | +25.7% |
| 8/4/2021 | $0.20 | $0.43 | +115.0% | $134.9M | $141.3M | +4.8% |
| 5/5/2021 | $0.24 | $0.11 | -54.2% | $129.4M | $130.9M | +1.2% |
| 2/25/2021 | $0.52 | $0.57 | +9.6% | $146.2M | $143.6M | -1.8% |
| 11/3/2020 | $0.30 | $0.74 | +146.7% | $24.4M | $155.1M | +536.1% |
| 8/18/2020 | $0.42 | $0.65 | +54.8% | $81.9M | $126.7M | +54.8% |
| 5/5/2020 | $0.28 | $0.40 | +42.9% | $66.5M | $95.0M | +42.9% |
| 2/25/2020 | $0.60 | $0.62 | +3.3% | $97.2M | $100.4M | +3.3% |
| 11/5/2019 | $0.60 | $0.54 | -10.0% | $113.5M | $102.1M | -10.0% |
| 8/6/2019 | $0.58 | $0.61 | +5.2% | $99.5M | $104.7M | +5.2% |
| 5/7/2019 | $0.47 | $0.34 | -27.7% | $118.2M | $85.5M | -27.7% |
| 2/26/2019 | $0.27 | $0.48 | +77.8% | $95.6M | $115.9M | +21.2% |
| 11/6/2018 | $0.41 | $0.52 | +26.8% | $81.2M | $103.0M | +26.8% |
| 8/7/2018 | $0.43 | $0.57 | +32.6% | $75.1M | $99.5M | +32.6% |
| 5/8/2018 | $0.33 | $0.49 | +48.5% | $60.9M | $90.4M | +48.5% |
| 2/27/2018 | $0.26 | $0.44 | +69.2% | $54.3M | $88.4M | +63.0% |
| 11/6/2017 | $0.27 | $0.29 | +7.4% | $74.9M | $80.4M | +7.4% |
| 8/2/2017 | $0.24 | $0.32 | +33.3% | $56.9M | $75.8M | +33.3% |
| 5/9/2017 | $0.22 | $0.19 | -13.6% | $66.7M | $57.6M | -13.6% |
| 2/28/2017 | $0.25 | $0.26 | +4.0% | $60.0M | $62.4M | +4.0% |
| 1/20/2017 | $0.34 | $0.37 | +8.8% | $18.0M | $56.8M | +216.1% |
| 8/2/2016 | $0.13 | $0.18 | +38.5% | $37.3M | $50.4M | +35.2% |
| 5/3/2016 | $0.09 | $0.08 | -11.1% | $49.7M | $43.1M | -13.4% |
| 3/2/2016 | $0.06 | $0.14 | +133.3% | $18.7M | $42.7M | +127.8% |
| 11/3/2015 | $0.02 | $0.08 | +243.3% | $10.1M | $38.6M | +280.2% |
| 8/4/2015 | $0.02 | $0.03 | +25.0% | $23.4M | $35.1M | +50.0% |
| 5/5/2015 | $0.01 | $0.05 | +300.0% | $14.1M | $28.1M | +100.0% |
| 3/10/2015 | $-0.12 | $0.10 | +183.3% | $37.0M | $30.8M | -16.7% |
| 11/11/2014 | $0.45 | $-0.20 | -144.4% | $48.5M | $52.5M | +8.3% |
| 8/11/2014 | $-0.18 | $0.06 | +133.3% | $55.6M | $29.7M | -46.7% |
| 5/12/2014 | $-0.44 | $-0.36 | +18.2% | $10.6M | $9.1M | -14.6% |
| 3/12/2014 | $-0.54 | $-0.39 | +27.8% | $14.6M | $10.3M | -29.1% |
| 11/12/2013 | $-0.66 | $-0.65 | +1.5% | $1.3M | $1.3M | -4.4% |
| 8/13/2013 | $-0.67 | $-0.57 | +14.9% | $320,438.6 | $281,000 | -12.3% |
| 5/13/2013 | $-0.63 | $-0.60 | +4.8% | $173,950 | $147,000 | -15.5% |
| 3/14/2013 | $-0.73 | $-0.51 | +30.1% | $1.5M | $1.1M | -28.1% |
| 11/7/2012 | $-0.57 | $-0.55 | +3.5% | $103,709.09 | $91,000 | -12.3% |
| 8/13/2012 | — | $-0.60 | — | — | $91,000 | — |
| 8/10/2012 | $-0.48 | $-0.61 | -27.1% | $71,606.56 | $208,000 | +190.5% |
| 12/31/2011 | — | $51.38 | — | — | $-9.8M | — |
| 9/30/2011 | — | $-6.10 | — | — | $11,000 | — |
| 6/30/2011 | — | $-4.63 | — | — | $750,000 | — |
| 3/31/2011 | — | $-0.80 | — | — | Pending | — |
| 12/31/2010 | — | $-0.62 | — | — | $-8.6M | — |
| 12/31/2009 | — | $-0.59 | — | — | $-5.1M | — |
Need SUPN data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.